IAPP antibody (Prothena)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameIAPP antibody (Prothena)
Drug Alias Nameantibody therapy (Prothena)antibody therapy (Neotope Biosciences)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProthena Corp Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProthena Corp Plc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A